Menu
Lecture 3: Dyslipidemia In African American

Lecture 3: Dyslipidemia I…

The objectives of...

Lipoprotein Pathology In Obesity: Part 2

Lipoprotein Pathology In …

The two part obes...

Cholesterol Trafficking

Cholesterol Trafficking

This interactive pr...

Coronary heart disease events in the Women’s Health Initiative hormone trials:

Coronary heart disease ev…

Coronary heart di...

What if obesity has nothing to do with overeating?

What if obesity has nothi…

Peter Attia, MD, o...

LIVE CASE PRESENTATION: Case 3

LIVE CASE PRESENTATION: C…

LIVE CASE PRESENTATI...

Summary of ADA Revised Standards of Medical Care in Diabetes 2012

Summary of ADA Revised St…

Diabetes is a dise...

Clinical Application of Plasma Sterols/Stanol Measurements

Clinical Application of P…

This lecture is int...

Lecture 4: Dyslipidemia In African American

Lecture 4: Dyslipidemia I…

The objectives of...

Prev Next
2014: Is it time to face facts about niacin?

2014: Is it time to face facts about niacin?

Although we were all aware of the null data from Heart Protection Study 2–Treatment of HDL to Reduce the Incidence of Vascular Events(HPS THRIVE II) which was released last year, the study was finally published in the New England Journa...

Latest Lectures

Framingham Offspring Populat…

M any providers get various lipid concentrations and often do not understand ...

The Ying and Yang of Lipid-modifying agents: CETP Inhibitors

The Ying and Yang of Lipid-m…

The Ying and Yang of Lipid-modifying agents: CETP Inhibitors - are they on li...

Examination of the recently announced preliminary results of the HPS2-THRIVE study

Examination of the recently …

Niacin: A Failure to THRIVE?   This is an examination of...

What if obesity has nothing to do with overeating?

What if obesity has nothing …

Peter Attia, MD, once judged patients who were overweight or obese until, desp...

More Lectures!